StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.19−0.31 (-1.38%)

Close on Nov 20, 2026Market cap $451.80MP/E –Yield –

Assembly Biosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Assembly Biosciences's free cash flow for the twelve months ending Jun 30, 2026 was -$38.57M. For fiscal 2025 it was -$41.16M. The highest annual figure on record is $22.49M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$41.16M–
FY2024Dec 31, 2024-$51.15M-327.4%
FY2023Dec 31, 2023$22.49M–
FY2022Dec 31, 2022-$84.57M–
FY2021Dec 31, 2021-$96.49M–
FY2020Dec 31, 2020-$63.43M–
FY2019Dec 31, 2019-$85.62M–
FY2018Dec 31, 2018-$65.30M-6662.6%
FY2017Dec 31, 2017$995.00K–
FY2016Dec 31, 2016-$35.03M–
FY2015Dec 31, 2015-$18.76M–
FY2014Dec 31, 2014-$15.12M–
FY2013Dec 31, 2013-$17.80M–
FY2012Dec 31, 2012-$21.38M–
FY2011Dec 31, 2011-$25.08M–
FY2010Dec 31, 2010-$5.21M–
FY2009Dec 31, 2009-$3.49M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.49M–
Q1 FY2026Mar 31, 2026-$22.12M–
Q4 FY2025Dec 31, 2025$14.21M–
Q3 FY2025Sep 30, 2025-$15.18M–
Q2 FY2025Jun 30, 2025-$16.76M–
Q1 FY2025Mar 31, 2025-$23.44M–
Q4 FY2024Dec 31, 2024-$407.00K-100.6%
Q3 FY2024Sep 30, 2024-$15.24M–
Q2 FY2024Jun 30, 2024-$17.12M–
Q1 FY2024Mar 31, 2024-$18.38M–
Q4 FY2023Dec 31, 2023$73.58M–
Q3 FY2023Sep 30, 2023-$13.98M–
Q2 FY2023Jun 30, 2023-$13.68M–
Q1 FY2023Mar 31, 2023-$23.43M–
Q4 FY2022Dec 31, 2022-$19.25M–
Q3 FY2022Sep 30, 2022-$19.92M–
Q2 FY2022Jun 30, 2022-$17.89M–
Q1 FY2022Mar 31, 2022-$27.50M–
Q4 FY2021Dec 31, 2021-$19.38M–
Q3 FY2021Sep 30, 2021-$18.88M-277.4%
Q2 FY2021Jun 30, 2021-$21.81M–
Q1 FY2021Mar 31, 2021-$36.42M–
Q4 FY2020Dec 31, 2020-$25.27M–
Q3 FY2020Sep 30, 2020$10.65M–
Q2 FY2020Jun 30, 2020-$23.52M–
Q1 FY2020Mar 31, 2020-$25.28M–
Q4 FY2019Dec 31, 2019-$20.54M–
Q3 FY2019Sep 30, 2019-$18.60M–
Q2 FY2019Jun 30, 2019-$21.06M–
Q1 FY2019Mar 31, 2019-$25.43M–
Q4 FY2018Dec 31, 2018-$16.94M–
Q3 FY2018Sep 30, 2018-$16.72M–
Q2 FY2018Jun 30, 2018-$16.10M–
Q1 FY2018Mar 31, 2018-$15.54M-144.5%
Q4 FY2017Dec 31, 2017-$10.13M–
Q3 FY2017Sep 30, 2017-$11.46M–
Q2 FY2017Jun 30, 2017-$12.36M–
Q1 FY2017Mar 31, 2017$34.94M–
Q4 FY2016Dec 31, 2016-$11.15M–
Q3 FY2016Sep 30, 2016-$7.90M–

More Assembly Biosciences figures

See a number that looks wrong?